Aileron Therapeutics’ unraveling has entered its endgame. An early look at phase 1b data persuaded the biotech to call it quits on development of its sole drug candidate—and lay off most of its ...

Lam Aviation advertised substantial performance gains (speed, fuel, climb, useful load) on a test aircraft, initially implying these improvements stemmed from their novel Lam aileron. The Lam aileron ...

Brett T. Evans has more than a decade of experience driving, writing about, and evaluating automobiles. His early career comprised writing about pre- and post-war classic cars, as well as late-model ...

If you buy something using links in our stories, we may earn a commission. This helps support our journalism. Learn more. Please also consider subscribing to WIRED Imagine a supercar with ideal ...

Aileron Therapeutics pulled a hard pivot in 2023, merging with Lung Therapeutics to gain a new pipeline and investor base. Now, the biotech has distanced itself from its premerger form by rebranding ...

Investigators are attempting to understand the reason behind unresponsive ailerons on De Havilland Canada Dash 8-400 turboprops, an anomaly discovered during a separate probe into an aileron cable ...

Whatever its credentials as a sports car—and they seem to be impressive—the Spyker C8 Aileron is an attention-getting device of pretty intense wattage. It even draws stares from the pilots of Ferraris ...

WALTHAM, Mass., Feb. 01, 2024 (GLOBE NEWSWIRE) -- Aileron Therapeutics, Inc. (“Aileron”) (NASDAQ: ALRN), a biopharmaceutical company advancing a novel pipeline of first-in-class medicines to address ...